Table 4.
Relationship between PLR value and tumor-related characteristics
| Variables | PLR | P value | |
|---|---|---|---|
| <125 ( n = 288) | ≥125 ( n = 55) | ||
| Tumor number >3 | 69 (24.0%) | 22 (40.0%) | 0.014 |
| Largest tumor size (cm) | |||
| ≤5 | 214 (74.3%) | 19 (34.5%) | 0.000 |
| 5 to 8 | 43 (14.9%) | 11 (20.0%) | |
| >8 | 31 (10.8%) | 25 (45.5%) | |
| Total tumor size (cm) | |||
| ≤5 | 144 (50.0%) | 10 (18.2%) | 0.000 |
| 5 to 8 | 46 (16.0%) | 8 (14.5%) | |
| >8 | 98 (34.0%) | 37 (67.3%) | |
| Macro-vascular invasion | 78 (27.1%) | 23 (41.8%) | 0.028 |
| Micro-vascular invasion | 109 (37.8%) | 33 (60.0%) | 0.002 |
| Tumor differentiation | |||
| Poor | 124 (43.1%) | 24 (43.6%) | 0.246 |
| Moderate | 141 (49.0%) | 30 (54.5%) | |
| Well | 23 (8.0%) | 1 (1.8%) | |
| AFP ≥200 ng/ml | 136 (47.2%) | 32 (58.2%) | 0.147 |
| Within Milan criteria | 135 (46.9%) | 9 (16.4%) | 0.000 |
| Within UCSF criteria | 156 (54.2%) | 10 (18.2%) | 0.000 |
| Within Hangzhou criteria | 177 (61.5%) | 16 (29.1%) | 0.000 |